tRF-19-W4PU732S promotes breast cancer cell malignant activity by targeting inhibition of RPL27A (ribosomal protein-L27A)

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Marklund L, Hammarstedt L. Impact of HPV in oropharyngeal cancer. J Oncol. 2011;2011:509036.
   PubMedGoogle Scholar
• Mo D, He F, Zheng J, et al. tRNA-derived fragment tRF-17-79MP9PP attenuates cell invasion and migration via THBS1/TGF-β1/Smad3 axis in breast cancer. Front Oncol. 2021;11:656078.
   PubMed Web of Science ®Google Scholar
• Wu X, Zeng R, Wu S, et al. Comprehensive expression analysis of miRNA in breast cancer at the miRNA and isomiR levels. Gene. 2015;557(2):195–200.
   PubMed Web of Science ®Google Scholar
• Montazeri M, Montazeri M, Montazeri M, et al. Machine learning models in breast cancer survival prediction. Technol Health Care. 2016;24:31–42.
   PubMed Web of Science ®Google Scholar
• Hamam R, Hamam D, Alsaleh KA, et al. Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers. Cell Death Dis. 2017;8(9):e3045.
   PubMed Web of Science ®Google Scholar
• Zhu L, Ge J, Li T, et al. tRNA-derived fragments and tRNA halves: the new players in cancers. Cancer Lett. 2019;452:31–37.
   PubMed Web of Science ®Google Scholar
• Sun C, Yang F, Zhang Y, et al. tRNA-derived fragments as novel predictive biomarkers for trastuzumab-resistant breast cancer. Cell Physiol Biochem. 2018;49(2):419–431.
   PubMedGoogle Scholar
• Shigematsu M, Kirino Y. 5′-Terminal nucleotide variations in human cytoplasmic tRNA HisGUG and its 5′-halves. RNA. 2017;23(2):161–168.
   PubMed Web of Science ®Google Scholar
• Keam SP, Hutvagner G. tRNA-derived fragments (tRFs): emerging new roles for an ancient RNA in the regulation of gene expression. Life (Basel). 2015;5(4):1638–1651.
   PubMedGoogle Scholar
• Huang B, Yang H, Cheng X, et al. tRF/miR-1280 suppresses stem cell-like cells and metastasis in colorectal cancer. Cancer Res. 2017;77(12):3194–3206.
   PubMed Web of Science ®Google Scholar
• Papadimitriou MA, Avgeris M, Levis P, et al. tRNA-derived fragments (tRFs) in bladder cancer: increased 5ʹ-tRF-LysCTT results in disease early progression and patients’ poor treatment outcome. Cancers (Basel). 2020;12(12):3661.
   PubMed Web of Science ®Google Scholar
• Wang J, Ma G, Ge H, et al. Circulating tRNA-derived small RNAs (tsRNAs) signature for the diagnosis and prognosis of breast cancer. NPJ Breast Cancer. 2021;7(1):4.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bi Z, Dong X, et al. tRNA-derived fragments: tRF-Gly-CCC-046, tRF-Tyr-GTA-010 and tRF-Pro-TGG-001 as novel diagnostic biomarkers for breast cancer. Thorac Cancer. 2021;12(17):2314–2323.
   Web of Science ®Google Scholar
• Jia Y, Tan W, Zhou Y. Transfer RNA-derived small RNAs: potential applications as novel biomarkers for disease diagnosis and prognosis. Ann Transl Med. 2020;8(17):1092.
   PubMed Web of Science ®Google Scholar
• Zhu P, Lu J, Zhi X, et al. tRNA-derived fragment tRF Lys-CTT-010 promotes triple-negative breast cancer progression by regulating glucose metabolism via G6PC. Carcinogenesis. 2021;42(9):1196–1207. .
   PubMed Web of Science ®Google Scholar
• Rio DC, Ares M Jr, Hannon GJ, et al. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb Protoc. 2010;2010(6): pdb.prot5439.
   Google Scholar
• Mo D, Jiang P, Yang Y, et al. A tRNA fragment, 5ʹ-tiRNAVal, suppresses the Wnt/β-catenin signaling pathway by targeting FZD3 in breast cancer. Cancer Lett. 2019;457:60–73.
   PubMed Web of Science ®Google Scholar
• Li SY, Zhu Y, Li RN, et al. LncRNA Lnc-APUE is repressed by HNF4 α and promotes G1/S phase transition and tumor growth by regulating miR-20b/E2F1 axis. Adv Sci (Weinh). 2021;8(7):2003094.
   PubMedGoogle Scholar
• Huang Q, Wang L, Ran Q, et al. Notopterol-induced apoptosis and differentiation in human acute myeloid leukemia HL-60 cells. Drug Des Devel Ther. 2019;13:1927–1940.
   PubMed Web of Science ®Google Scholar
• Li P, Xu T, Zhou X, et al. Downregulation of miRNA-141 in breast cancer cells is associated with cell migration and invasion: involvement of ANP32E targeting. Cancer Med. 2017;6(3):662–672.
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–451.
   PubMed Web of Science ®Google Scholar
• McDonald ES, Clark AS, Tchou J, et al. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57(1):9S–16S.
   PubMedGoogle Scholar
• Berry DA, Cronin KA, Plevritis SK, et al. Cancer Intervention and Surveillance Modeling Network (CISNET) collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–1792.
   PubMed Web of Science ®Google Scholar
• Wang J, Ma G, Li M, et al. Plasma tRNA fragments derived from 5ʹ ends as novel diagnostic biomarkers for early-stage breast cancer. Mol Ther Nucleic Acids. 2020;21:954–964.
   PubMedGoogle Scholar
• Farina NH, Scalia S, Adams CE, et al. Identification of tRNA-derived small RNA (tsRNA) responsive to the tumor suppressor, RUNX1, in breast cancer. J Cell Physiol. 2020;235(6):5318–5327.
   PubMed Web of Science ®Google Scholar
• Huang SQ, Sun B, Xiong ZP, et al. The dysregulation of tRNAs and tRNA derivatives in cancer. J Exp Clin Cancer Res. 2018;37:101.
   PubMed Web of Science ®Google Scholar
• Rashad S, Niizuma K, Tominaga T. tRNA cleavage: a new insight. Neural Regen Res. 2020;15(1):47–52.
   PubMed Web of Science ®Google Scholar
• Zhang M, Li F, Wang J, et al. tRNA-derived fragment tRF-03357 promotes cell proliferation, migration and invasion in high-grade serous ovarian cancer. Onco Targets Ther. 2019;12:6371–6383.
   PubMed Web of Science ®Google Scholar
• Frigerio JM, Dagorn JC, Iovanna JL. Cloning, sequencing and expression of the L5, L21, L27a, L28, S5, S9, S10 and S29 human ribosomal protein mRNAs. Biochim Biophys Acta. 1995;1262(1):64–68.
   PubMed Web of Science ®Google Scholar
• Alkhatabi HA, McLornan DP, Kulasekararaj AG, et al. RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis. Oncotarget. 2016;7(30):47875–47890.
   PubMedGoogle Scholar
• Zubor P, Hatok J, Moricova P, et al. Gene expression profiling of histologically normal breast tissue in females with human epidermal growth factor receptor 2‑positive breast cancer. Mol Med Rep. 2015;11(2):1421–1427.
   PubMed Web of Science ®Google Scholar
• Varis A, Wolf M, Monni O, et al. Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res. 2002;62(9):2625–2629.
   PubMed Web of Science ®Google Scholar
• Terzian T, Dumble M, Arbab F, et al. Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models. J Pathol. 2011;224(4):540–552.
   PubMed Web of Science ®Google Scholar